novo oral glp 1 Novo's Rybelsus gains FDA expansion to reduce risk of MACE Novo Nordisk seeks approval for

New research highlights the use of #GLP1 receptor agonists (like semaglutide &amp

791 new AEs surfaced From audio to email, chatbot to scanned fax, Vigilance Detect extracts safety data with precision

#Sematide #No1_PrescribedGLP1_in_Pakistan #Most_TrustedGLP1 #Turning_the_Tide #Putting_Patients_First #HealthCareImpact #Pharmaceuticals #Ferozsons_Labs #BFBiosciences

Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c

Constipation is a common but often overlooked side effect in people taking GLP-1 receptor agonists, a class of medications widely used to treat obesity and type 2 diabetes